✦ LIBER ✦

Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema

✍ Scribed by HENZ; JABLONSKA; VAN DE KERKHOF; STINGL; BLASZCZYK; VANDERVALK; VEENHUIZEN; MUGGLI; RAEDERSTORFF

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 129 KB
Volume: 140
Category: Article
ISSN: 0007-0963
DOI: 10.1046/j.1365-2133.1999.02771.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicentre double-blind placebo-contr

A multicentre double-blind placebo-controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalized anxiety

✍ T. Darcis; M. Ferreri; J. Natens; B. Burtin; P. Deram 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

The efficacy of hydroxyzine was investigated in 110 patients suffering from generalized anxiety, in a double-blind placebo controlled multicentre study. Oral hydroxyzine 50mg/day for four weeks significantly improved standard measurements of anxiety compared with placebo control. These improvements

Evaluation of the efficacy and tolerabil

Evaluation of the efficacy and tolerability of oral terbinafine (Daskil®) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial

✍ E. Scaparro; G. Quadri; G. Virno; C. Orifici; M. Milani 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Efficacy and tolerability of duloxetine

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies

✍ Jonathan Davidson; Christer Allgulander; Mark H. Pollack; James Hartford; Janell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD). ## Methods Acute‐phase data from a subset of patients (≥65 years) with GAD were pooled from four randomized, double‐blind, placebo‐controlled trials of dulo

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

GCP audit findings - case study no. 2. A

GCP audit findings - case study no. 2. A multicentre double-blind study to compare the safety and efficacy of drug X with marketed drug Y in patients with unstable angina undergoing cardiovascular surgery

✍ Wendy Bohaychuk; Graham Ball 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

A double-blind comparison of the efficac

A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis

✍ S. Diallo; M.A. Aziz; M. Lariviere; J.S. Diallo; I. Diop-Mar; O. N'Dir; S. Badia 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 838 KB